Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation

Cytotherapy

Volumn 8, Issue 5, 2006, Pages 473-479

  Schnabel, B ^a   Schmidmaier, R ^a   Franke, D ^a   Emmerich, B ^a   Straka, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Autologous stem cell transplantation; High dose chemotherapy; Infection; Leukopenia; Multiple myeloma; Neutropenic fever; T lymphocytes

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CD4+ T LYMPHOCYTE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFECTION; INFECTION RESISTANCE; INFECTION RISK; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFUSION; MALE; MONOCYTE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; FEMALE; FEVER; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPENIA; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33750154614     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240600941531     Document Type: Article

References (25)

1. Attal, M and Harousseau, JL and Stoppa, AM and (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med, 335, pp. 91-7.
2. Barlogie, B and Jagannath, S and Desikan, KR and (1999) Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood, 93, pp. 55-65.
3. Child, JA and Morgan, GJ and Davies, FE and (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma N Engl J Med, 348, pp. 1875-83.
4. Attal, M and Harousseau, JL and Facon, T and (2003) Single versus double autologous stem-cell transplantation for multiple myeloma N Engl J Med, 349, pp. 2495-502.
5. Palumbo, A and Bringhen, S and Petrucci, MT and (2004) Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: Results of a randomized controlled trial Blood, 104, pp. 3052-7.
6. Auner, HW and Sill, H and Mulabecirovic, A and (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukaemia, malignant lymphoma, and multiple myeloma Ann Hematol, 81, pp. 374-7.
7. Reich, G and Mapara, MY and Reichardt, P and (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: Comparison between patients with lymphoma or multiple myeloma and patients with solid tumors Bone Marrow Transplant, 27, pp. 525-9.
8. Straka, C and Oduncu, F and Hinke, A and (2004) Responsiveness to G-CSF before leukopenia predicts defense to infection in high-dose chemotherapy recipients Blood, 104, pp. 1989-94.
9. Hughes, WT and Armstrong, D and Bodey, GP and (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America Clin Infect Dis, 25, pp. 551-73.
10. Zambelli, A and Montagna, D and Da Prada, GA and (2002) Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients Anticancer Res, 22, pp. 3701-8.
11. Offidani, M and Corvatta, L and Olivieri, A and (1999) Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF Bone Marrow Transplant, 24, pp. 1079-87.
12. Tricot, G and Jagannath, S and Vesole, D and (1995) Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients Blood, 85, pp. 588-96.
13. Ketterer, N and Salles, G and Raba, M and (1998) High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation Blood, 91, pp. 3148-55.
14. Weaver, CH and Hazelton, B and Birch, R and (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy Blood, 86, pp. 3961-9.
15. Dayyani, F and Joeinig, A and Ziegler-Heitbrock, L and (2004) Autologous stem-cell transplantation restores the functional properties of CD14+ CD16+ monocytes in patients with myeloma and lymphoma J Leukoc Biol, 75, pp. 207-13.
16. Bodey, GP and Buckley, M and Sathe, YS and Freireich, EJ. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med, 64, pp. 328-40.
17. Kim, DH and Kim, JG and Sohn, SK and (2004) Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation Br J Haematol, 125, pp. 217-24.
18. Einsele, H and Ehninger, G and Steidl, M and (1993) Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation Blood, 82, pp. 1672-8.
19. Steingrimsdottir, H and Gruber, A and Bjorkholm, M and (2000) Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications Haematologica, 85, pp. 832-8.
20. Krause, SW and Rothe, G and Gnad, M and (2003) Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation Ann Hematol, 82, pp. 628-36.
21. Chen, BJ and Cui, X and Sempowski, GD and (2004) Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation Blood, 103, pp. 4344-52.
22. + cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation Bone Marrow Transplant, 23, pp. 1177-81.
23. + cells provides a rapid hematopoietic recovery and cost savings in autologous peripheral blood stem cell transplantation Jpn J Clin Oncol, 32, pp. 135-9.
24. Fagnoni, FF and Lozza, L and Libera, C and (2003) Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation Bone Marrow Transplant, 31, pp. 31-8.
25. Condomines, M and Quittet, P and Lu, Z-Y and (2006) Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor J Immunol, 176, pp. 6631-9.